Working… Menu

Anlotinib and Irinotecan for Ewing Sarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03416517
Recruitment Status : Unknown
Verified February 2019 by GUO WEI, Peking University People's Hospital.
Recruitment status was:  Recruiting
First Posted : January 31, 2018
Last Update Posted : February 15, 2019
Information provided by (Responsible Party):
GUO WEI, Peking University People's Hospital

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : December 2020